Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model

Journal of Orthopaedic Research

Volumn 28, Issue 4, 2010, Pages 451-456

  Zhou, Xiaoxiao ^a,b   Zhang, Peng ^c   Zhang, Chao ^d   Zhu, Zhen'an ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TAIZHOU CENTRAL HOSPITAL   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Bone formation; Naringin; Osteolysis; Rhizoma drynariae; Type 1 diabetes

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; AURANTIIN; OSTEOCALCIN; TITANIUM; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; FLAVANONE DERIVATIVE; HERBACEOUS AGENT; PEPTIDE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALVARIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOZOCIN DIABETES; ANIMAL; BLOOD; BONE DEVELOPMENT; BONE PROSTHESIS; C57BL MOUSE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; EXPERIMENTAL DIABETES MELLITUS; FRACTURE HEALING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYTOTHERAPY; POLYPODIACEAE; SKULL;

ANIMALS; BONE SUBSTITUTES; COLLAGEN TYPE I; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUGS, CHINESE HERBAL; FLAVANONES; FRACTURE HEALING; MALE; MICE; MICE, INBRED C57BL; OSTEOCALCIN; OSTEOGENESIS; OSTEOLYSIS; PEPTIDES; PHYTOTHERAPY; PLANT EXTRACTS; POLYPODIACEAE; SKULL; TITANIUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949533144     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21002     Document Type: Article

References (43)

1. Dixon T, Shaw M, Ebrahim S, et al. 2004. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. Ann Rheum Dis 63:825-830.
2. Kurtz S, Mowat F, Ong K, et al. 2005. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through2002. J Bone Joint Surg [Am] 87: 1487-1497.
3. Kurtz S, Ong K, Lau E, et al. 2007. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg [Am] 89:780-785.
4. Honeycutt AA, Boyle JP, Broglio KR, et al. 2003. A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manage Sci 6:155-164.
5. Narayan KM, Boyle JP, Thompson TJ, et al. 2003. Lifetime risk for diabetes mellitus in the United States. JAMA 290: 1884-1890.
6. Meding JB, Reddleman K, Keating ME, et al. 2003. Total knee replacement in patients with diabetes mellitus. Clin Orthop 416:208-216.
7. Pagagelopoulos PJ, Idusuyi OB, Wallrichs SL, et al. 1996. Long-term outcome and survivorship analysis of primary total knee arthroplasty in patients with diabetes mellitus. Clin Orthop 330:124-132.
8. Serna F, Mont MA, Krackow KA, et al. 1994. Total knee arthroplasty in diabetic patients. Comparison to a matched control. J Arthroplasty 9:375-379.
9. Johnston RC, Fitzgerald RH, Harris WH, et al. 1990. Clinical and radiological evaluation of total hip replacement. A standard system of terminology for reporting results. J Bone Joint Surg 72:161-168.
10. Krakauer JC, McKenna MJ, Buderer NF, et al. 1995. Bone loss and bone turnover in diabetes. Diabetes 44:775-782.
11. Hui SL, Epstein S, Johnston CC Jr. 1985. A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab 60:74-80.
12. Loder RT. 1988. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 232:210-216.
13. Lopez-Ibarra PJ, Pastor MM, Escobar-Jimenez F, et al. 2001. Bone mineral density at time of clinical diagnosis of adultonset type 1 diabetes mellitus. Endocr Pract 7:346-351.
14. Kemink SA, Hermus AR, Swinkels LM, et al. 2000. Osteopenia in insulin-dependent diabetes mellitus: prevalence and aspects of pathophysiology. J Endocrinol Invest 23:295-303.
15. Lühe A, Künkele KP, Haiker M, et al. 2008. Pre-clinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety. Toxicol In Vitro 22:899-909.
16. Hamburger M. 2007. New approaches in analyzing the pharmacological properties of herbal extracts. Proc West Pharmacol Soc 50:156-161.
17. Yu L, Ao M, Wan J, et al. 2008. Anti-inflammatory effects of leaf and twig of Tripterygium wilfordii on paw edema in mice. Fitoterapia 79:529-532.
18. Zheng JW, Zhou GY, Wang YA, et al. 2008. Management of head and neck hemangiomas in China. Chin Med J [Engl] 121: 1037-1042.
19. Wong RW, Rabie B, Bendeus M, et al. 2007. The effects of Rhizoma curculiginis and Rhizoma drynariae extracts on bones. Chin Med 2:13-19.
20. Jeong JC, Lee JW, Yoon CH, et al. 2005. Stimulative effects of drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells. J Ethnopharmacol 96:489-495.
21. Jeong JC, Kang SK, Youn CH, et al. 2003. Inhibition of drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int Immunopharmacol 3:1685-1697.
22. Zhou FR, Zhang ZQ. 1994. Quality evaluation of 3 kinds of Rhizoma drynariae. Zhongguo Zhong Yao Za Zhi 19:261-263.
23. Manthey JA, Grohmann K. 2001. Phenols in citrus peel byproducts. Concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses. J Agric Food Chem 49:3268-3273.
24. Wei M, Yang Z, Li P, et al. 2007. Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med 35:663-667.
25. Wu JB, Fong YC, Tsai HY, et al. 2008. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/ c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 588: 333-341.
26. Wong RW, Rabie AB. 2006. Effect of naringin collage graft on bone formation. Biomaterial 27:1824-1831.
27. Peng-Zhang Dai KR, Yan SG, et al. 2009. Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol 607:1-5.
28. Merkel KD, Erdmann JM, McHugh KP, et al. 1999. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 154:203-210.
29. Wedemeyer C, von Knoch F, Pingsmann A, et al. 2005. Stimulation of bone formation by zoledronic acid in particleinduced osteolysis. Biomaterials 26:3719-3725.
30. Bi Y, Van De Motter RR, Ragab AA, et al. 2001. Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. J Bone Joint Surg [Am] 83-A:501-508.
31. Von Knoch M, Jewison DE, Sibonga JD, et al. 2004. The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. J Orthop Res 22:237-243.
32. Like AA, Rossini AA. 1976. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415-417.
33. Wright JR Jr, Lefkowith JB, Schreiner G, et al. 1988. Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice. Proc Natl Acad Sci USA 85:6137-6141.
34. Childs LM, Goater JJ, O'Keefe RJ, et al. 2001. Effect of antitumor necrosis factor-alpha gene therapy on wear debrisinduced osteolysis. J Bone Joint Surg [Am] 83-A:1789-1797.
35. Wedemeyer C, Neuerburg C, Pfeiffer A, et al. 2007. Polyethylene particle-induced bone resorption in substance P-deficient mice. Calcif Tissue Int 80:268-274.
36. Schwarz EM, Lu AP, Goater JJ, et al. 2000. Tumor necrosis factor-alpha/nuclear transcription factor-kappa B signaling in periprosthetic osteolysis. J Orthop Res 18:472-480.
37. Von Knoch F, Wedemeyer C, Heckelei A, et al. 2005. Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysis. Biomaterials 26:5783-5789.
38. Wedemeyer C, Xu J, Neuerburg C, et al. 2007. Particleinduced osteolysis in three-dimensional micro-computed tomography. Calcif Tissue Int 81:394-402.
39. Hough S, Avioli LV, Bergfeld MA, et al. 1981. Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. Endocrinology 108:2228-2234.
40. Kroyer G. 1986. The antioxidant activity of citrus fruit peels. Z Ernahrungswiss 25:63-69.
41. Chen YT, Zheng RL, Jia ZJ, et al. 1990. Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 9:9-21.
42. Francis AR, Shetty TK, Bhattacharya RK. 1989. Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis 10:1953-1955.
43. Kaar SG, Ragab AA, Kaye SJ, et al. 2001. Rapid repair of titanium particle-induced osteolysis is dramatically reduced in aged mice. J Orthop Res 19:171-178.